Acetris

Subscribe to Acetris via RSS

What Does it Mean to Manufacture? Federal Circuit’s Acetris Decision Fundamentally Alters Trade Agreements Act Compliance

By David Gallacher, Ryan Roberts & Ariel Debin Collinsworth on February 27, 2020

Posted in Compliance, Domestic Preferences, Healthcare, Supply Chain, TAA

On February 10, 2020, the U.S. Court of Appeals for the Federal Circuit issued its long-awaited decision in Acetris Health LLC v. United States, No. 2018-2399 (Feb. 10, 2020).
Continue Reading What Does it Mean to Manufacture? Federal Circuit’s Acetris Decision Fundamentally Alters Trade Agreements Act Compliance

Federal Circuit Changes the Game for Selling Single-API Drugs to the Government

By Keeley A. McCarty on February 27, 2020

Posted in Compliance, Department of Veterans Affairs, Domestic Preferences, Healthcare, Supply Chain, TAA

Selling drugs to the Government just got a lot simpler. In Acetris Health LLC v. United States, No. 2018-2399 (Feb. 10, 2020), the Federal Circuit opened the Government door…
Continue Reading Federal Circuit Changes the Game for Selling Single-API Drugs to the Government

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.